Clinical Trials Directory

Trials / Completed

CompletedNCT00188903

Diastolic Dysfunction and Atrial Fibrillation in CABG Surgery

Diastolic Dysfunction and Atrial Fibrillation in Patients Undergoing Coronary Revascularization Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Left ventricular (LV) diastolic dysfunction is a common manifestation of heart disease that is responsible for significant morbidity and mortality.It is present when the ventricular filling is impaired as a result of delayed relaxation or decreased compliance. During Coronary artery bypass grafting (CABG) surgery, LV diastolic dysfunction is a frequent occurrence. Failure of the left ventricle to dilate normally causes an increase in LV filling pressure. Atrial fibrillation (AF) is a common complication after cardiac surgery affecting 20-30% of patients undergoing coronary revascularization procedures. AF is associated with significant morbidity and mortality and has been identified as a causative factor of increased length of both hospital and intensive care unit (ICU) stay after CABG surgery, resulting in increased resource utilization and medical care costs.The primary aim of this study is to determine if patients with preoperative diastolic dysfunction are exposed to higher risk of AF after coronary revascularization surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREDiastolic measurements during TEETransesophageal echocardiography with diastolic measurements

Timeline

Start date
2004-03-01
Primary completion
2007-11-01
Completion
2010-03-01
First posted
2005-09-16
Last updated
2010-08-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00188903. Inclusion in this directory is not an endorsement.